Follow this preprint
Elapsed time since BNT162b2 vaccine and risk of SARS-CoV-2 infection in a large cohort
Ariel Israel, View ORCID ProfileEugene Merzon, Alejandro A. Schäffer, Yotam Shenhar, Ilan Green, Avivit Golan-Cohen, Eytan Ruppin, Eli Magen, Shlomo Vinker
doi: https://doi.org/10.1101/2021.08.03.21261496
Now published in BMJ doi: 10.1136/bmj-2021-067873
Ariel Israel
1Leumit Research Institute & Department of Family Medicine, Leumit Health Services, Israel
M.D., Ph.D.Eugene Merzon
1Leumit Research Institute & Department of Family Medicine, Leumit Health Services, Israel
3Department of Family Medicine, Sackler Faculty of Medicine, Tel-Aviv University, Israel
M.D.Alejandro A. Schäffer
2Cancer Data Science Laboratory, National Cancer Institute, Bethesda, MD USA
Ph.D.Yotam Shenhar
1Leumit Research Institute & Department of Family Medicine, Leumit Health Services, Israel
Ph.D.Ilan Green
1Leumit Research Institute & Department of Family Medicine, Leumit Health Services, Israel
3Department of Family Medicine, Sackler Faculty of Medicine, Tel-Aviv University, Israel
M.D.Avivit Golan-Cohen
1Leumit Research Institute & Department of Family Medicine, Leumit Health Services, Israel
3Department of Family Medicine, Sackler Faculty of Medicine, Tel-Aviv University, Israel
M.D.Eytan Ruppin
2Cancer Data Science Laboratory, National Cancer Institute, Bethesda, MD USA
M.D., Ph.DEli Magen
1Leumit Research Institute & Department of Family Medicine, Leumit Health Services, Israel
4Medicine C Department, Clinical Immunology and Allergy Division, Barzilai University Medical Center, Ben-Gurion University of the Negev, Ashkelon, Israel
M.D., Ph.D.Shlomo Vinker
1Leumit Research Institute & Department of Family Medicine, Leumit Health Services, Israel
3Department of Family Medicine, Sackler Faculty of Medicine, Tel-Aviv University, Israel
M.D., M.H.A.
Article usage
Picked up by 81 news outlets
Blogged by 8
Referenced in 4 policy documents
Tweeted by 1979
On 3 Facebook pages
51 readers on Mendeley
Posted August 05, 2021.
Elapsed time since BNT162b2 vaccine and risk of SARS-CoV-2 infection in a large cohort
Ariel Israel, Eugene Merzon, Alejandro A. Schäffer, Yotam Shenhar, Ilan Green, Avivit Golan-Cohen, Eytan Ruppin, Eli Magen, Shlomo Vinker
medRxiv 2021.08.03.21261496; doi: https://doi.org/10.1101/2021.08.03.21261496
Now published in BMJ doi: 10.1136/bmj-2021-067873
Subject Area
Reviews and Context
8
Comment
0
TRIP Peer Reviews
2
Community Reviews
0
Automated Services
89
Blogs/Media
0
Author Videos
Subject Areas
- Addiction Medicine (419)
- Allergy and Immunology (741)
- Anesthesia (217)
- Cardiovascular Medicine (3199)
- Dermatology (270)
- Emergency Medicine (474)
- Epidemiology (13195)
- Forensic Medicine (19)
- Gastroenterology (884)
- Genetic and Genomic Medicine (5024)
- Geriatric Medicine (468)
- Health Economics (768)
- Health Informatics (3162)
- Health Policy (1121)
- Hematology (418)
- HIV/AIDS (996)
- Medical Education (467)
- Medical Ethics (124)
- Nephrology (512)
- Neurology (4770)
- Nursing (253)
- Nutrition (706)
- Oncology (2459)
- Ophthalmology (697)
- Orthopedics (275)
- Otolaryngology (335)
- Pain Medicine (318)
- Palliative Medicine (89)
- Pathology (527)
- Pediatrics (1271)
- Primary Care Research (544)
- Public and Global Health (7333)
- Radiology and Imaging (1656)
- Respiratory Medicine (959)
- Rheumatology (469)
- Sports Medicine (413)
- Surgery (532)
- Toxicology (68)
- Transplantation (227)
- Urology (197)